Dr. Anna Franklin, MD

NPI: 1700857380
Total Payments
$7,122
2022 Payments
$3,011
Companies
6
Transactions
23

Payment Breakdown by Category

Travel$5,147 (72.3%)
Consulting$1,325 (18.6%)
Food & Beverage$650.36 (9.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $5,147 9 72.3%
Consulting Fee $1,325 2 18.6%
Food and Beverage $650.36 12 9.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $5,724 8 $0 (2022)
Merck Sharp & Dohme Corporation $846.99 8 $0 (2019)
Janssen Research & Development, LLC $376.36 4 $0 (2018)
Amgen Inc. $102.19 1 $0 (2020)
E.R. Squibb & Sons, L.L.C. $61.09 1 $0 (2018)
Bayer HealthCare Pharmaceuticals Inc. $12.17 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2022 $3,011 2 Takeda Pharmaceuticals U.S.A., Inc. ($3,011)
2021 $450.00 1 Takeda Pharmaceuticals U.S.A., Inc. ($450.00)
2020 $102.19 1 Amgen Inc. ($102.19)
2019 $3,110 13 Takeda Pharmaceuticals U.S.A., Inc. ($2,263)
2018 $437.45 5 Janssen Research & Development, LLC ($376.36)
2017 $12.17 1 Bayer HealthCare Pharmaceuticals Inc. ($12.17)

All Payment Transactions

23 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/11/2022 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Drug) Travel and Lodging In-kind items and services $2,859.89 General
Category: ONCOLOGY
11/11/2022 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Drug) Travel and Lodging In-kind items and services $150.78 General
Category: ONCOLOGY
08/10/2021 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Drug) Consulting Fee Cash or cash equivalent $450.00 General
Category: ONCOLOGY
01/09/2020 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $102.19 General
Category: Oncology
11/20/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $60.00 General
Category: ONCOLOGY
11/20/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $50.00 General
Category: ONCOLOGY
11/20/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage Cash or cash equivalent $38.21 General
Category: ONCOLOGY
11/20/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $30.00 General
Category: ONCOLOGY
11/19/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Travel and Lodging In-kind items and services $321.55 General
Category: ONCOLOGY
11/19/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Travel and Lodging In-kind items and services $213.23 General
Category: ONCOLOGY
11/19/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $100.00 General
Category: ONCOLOGY
11/19/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Travel and Lodging Cash or cash equivalent $34.00 General
Category: ONCOLOGY
05/02/2019 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Biological) Consulting Fee Cash or cash equivalent $875.00 General
Category: Oncology
05/02/2019 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Biological) Travel and Lodging In-kind items and services $626.60 General
Category: Oncology
05/02/2019 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Biological) Travel and Lodging In-kind items and services $577.71 General
Category: Oncology
05/02/2019 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Biological) Food and Beverage Cash or cash equivalent $101.71 General
Category: Oncology
05/02/2019 Takeda Pharmaceuticals U.S.A., Inc. ADCETRIS (Biological) Travel and Lodging Cash or cash equivalent $81.89 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Travel and Lodging In-kind items and services $281.37 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $14.99 General
Category: Oncology
10/02/2018 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $61.09 General
12/05/2017 Bayer HealthCare Pharmaceuticals Inc. Aliqopa (Drug) Food and Beverage In-kind items and services $12.17 General
Category: Oncology

About Dr. Anna Franklin, MD

Dr. Anna Franklin, MD is a Pediatrics healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700857380.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Franklin, MD has received a total of $7,122 in payments from pharmaceutical and medical device companies, with $3,011 received in 2022. These payments were reported across 23 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($5,147).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Hematology-Oncology, Pediatric Hematology-Oncology
  • Location Aurora, CO
  • Active Since 01/31/2006
  • Last Updated 07/06/2016
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1700857380

Products in Payments

  • ADCETRIS (Drug) $3,461
  • ADCETRIS (Biological) $2,263
  • KEYTRUDA (Biological) $846.99
  • DARZALEX (Drug) $376.36
  • Blincyto (Biological) $102.19
  • Aliqopa (Drug) $12.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Aurora